Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Chemotherapy Induced Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Chemotherapy Induced Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Iron Deficiency Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Iron Deficiency Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Anemia in Chronic Kidney Disease (Renal Anemia) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline candidate, details of ... Read More
-
Fanconi Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Fanconi Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Global Hemophilia Drugs Market Growth 2023-2029
... factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab’ by Roche has demonstrated promising results regarding ... Read More
-
Global Anemia and Vitamin Test Market Growth (Status and Outlook) 2023-2029
... important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or low level of haemoglobin that ... Read More
-
Iron Deficiency Anemia Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Iron Deficiency Anemia market report analyzes the Iron Deficiency Anemia market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
-
Sickle Cell Anemia Testing & Screening Market Intelligence Report - Global Forecast 2023-2030
... in 2022, at a CAGR 13.49% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Iron Deficiency Anemia Therapy Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... - 2027). The COVID-19 pandemic had a significant impact on the healthcare systems, with significant consequences not only for COVID-19-infected patients but also for others, resulting in the cancellation of treatment and procedures to manage ... Read More
-
Global Rare Haematology Market - 2023-2030
... CAGR of XX% during the forecast period (2023-2030). A small number of individuals have rare blood diseases. They can impact platelets, red blood cells, or white blood cells, which makes it challenging to transfer oxygen ... Read More
-
Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2023-2029
... a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. ... Read More
-
Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Report 2022
... worth US$ 674.7 million in 2022 and is forecast to a readjusted size of US$ 1314.68 million by 2028 with a CAGR of 11.76% during the review period. Fully considering the economic change by this ... Read More
-
Bleeding Disorders Treatment Global Market Report 2022: Ukraine-Russia War Impact
... information they need to assess the global bleeding disorders treatment market. This report focuses on bleeding disorders treatment market which is experiencing strong growth. The report gives a guide to the bleeding disorders treatment market ... Read More
-
Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Chronic Kidney Disease (Renal Anemia) - Drugs In Development, 2022, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape. Renal anemia is a disease in which the patient ... Read More
-
Europe Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028
... The Europe Hemoglobinopathies Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028). HbS, HbD, HbE, and HbG are more frequently seen as beta-globin variants. A mutation in one beta globin component ... Read More
-
Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Regional Outlook and Forecast, 2022 - 2028
... The Global Hemoglobinopathies Market size is expected to reach $6.0 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period. In its stable state, normal human hemoglobin’s are tetrameric protein ... Read More
-
North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028
... 2028 The North America Hemoglobinopathies Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028). Tetramer hemoglobin consists of two alpha globin and two non-alpha globin chains, and Heme works together to ... Read More
-
Middle East & Africa Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)
... Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies) The MEA blood transfusion diagnostics market is expected to grow from US$ 151.99 million in 2022 to US$ 199.02 million by 2028. It is estimated to grow ... Read More
-
South America Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)
... Blood Banks, and Plasma Fractionation Companies) The SAM blood transfusion diagnostics market is expected to grow from US$ 217.55 million in 2022 to US$ 302.89 million by 2028. It is estimated to grow at a ... Read More
-
Fanconi Anemia - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hemophilia B (Factor IX Deficiency) Clinical trials scenario. This report provides ... Read More
-
Rare Hemophilia Factors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... notably impacted the healthcare sector. As per the article published in 2022 under the title ‘Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication’, eight days after receiving the first dose of the ... Read More
-
Global Aplastic Anemia Market - 2022-2029
... during the forecast period (2022-2029). Aplastic anemia is a condition that happens when the body stops generating sufficient new blood cells. The condition leaves a person tired and more prone to uncontrolled bleeding and infections. ... Read More
-
Thalassemia Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Iron Chelating Drugs, Blood Transfusions, Folic Acid Supplements, Gene Therapy, Others); By End-Use; By Disease Type; By Region; Segment Forecast, 2022 - 2030
... global thalassemia market size is expected to reach USD 1,492.9 billion by 2030, according to a new study by Polaris Market Research. The report “Thalassemia Market Share, Size, Trends, Industry Analysis Report, By Treatment Type ... Read More
Research Assistance
